Skip to main content
Caplight Logo









Resyca BV

Resyca BV

Private
EnschedeHealthcare & Life Scienceshttps://resyca.com/

Last Round

Corporate Funding

Nov 17, 2020

Est. Valuation

$35.29M

Total Funding Raised

$18M

Company Overview

Resyca BV is a healthcare technology company that specializes in the development and manufacturing of soft mist inhalation and nasal spray devices for pharmaceutical and biotech applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

drug-device combinationsoft mist inhalernasal delivery devicemicro-nozzle technologypre-filled syringe inhalerPFSIneedle-free injectionpulmonary drug deliveryintranasal therapybiologic deliveryaerosol deliverypharma contract manufacturingCDMOdrug delivery systemsmedical device development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Resyca BV Comparables

Compare Resyca BV with similar companies based on industry and business-model similarity.

Resyca BV comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medspray B.V.
85%
Merxin Ltd
80%
Suzhou Singmed Medical Device Science and Technology Ltd.
79%

Resyca BV Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingNov 17, 2020

Key People

Founding team and executive leadership

Deborah Jones

Chief Executive Officer

Executive Team

Bernhard Müllinger

Chief Operating Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 11, 2026

    Grew 33% QoQ from 9 to 12 employees.

  • Jan 25, 2025

    Monthly visitors grew 108% MoM, reaching 1.8K.

Resyca BV Filings

Explore SEC and related filing metadata, where available.

Resyca BV filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Resyca BV's valuation, stock price, and market status.

Is Resyca BV a public or private company?

Resyca BV is a private company.

What is the current stock price of Resyca BV?

Resyca BV is a private company with no public stock price. Caplight tracks Resyca BV's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Resyca BV worth (valuation)?

Resyca BV's valuation is estimated at $35.3M based on funding round data.

Can I buy Resyca BV stock?

Resyca BV shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Resyca BV's last funding round?

Resyca BV's most recent funding round was Corporate Funding on November 17, 2020.

Who are the main investors in Resyca BV?

Investor information for Resyca BV is not publicly disclosed.

Will Resyca BV IPO soon?

No public IPO plans have been announced for Resyca BV.

How can I track Resyca BV secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Resyca BV's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEnschede
Employee Range14
Year Founded2020
Last FundingNov 17, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?